Pegasta

Pegasta Product Image

Rs.3,550.00

Pegasta

(12 customer reviews)

Pegasta, developed by Intas, contains Pegfilgrastim 6mg and is used to stimulate the production of white blood cells in cancer patients undergoing chemotherapy. By increasing the number of neutrophils, Pegasta reduces the risk of infections, helping patients recover faster and stay safe during treatment.

Brand: Intas Composition: Pegfilgrastim 6mg

Product Introduction

Pegasta is a vital medication used in the management of neutropenia, a condition caused by chemotherapy. It works by stimulating the bone marrow to produce more white blood cells, helping the body fight infections more effectively during cancer treatment. With its highly effective formulation, Pegasta plays a crucial role in the supportive care of cancer patients.

Pegasta has been proven to reduce the frequency and duration of neutropenia episodes in patients, significantly improving their ability to tolerate chemotherapy treatments. It is a trusted choice among healthcare providers to enhance the quality of life for cancer patients.

Uses of Pegasta

Pegasta is primarily used for:

Pegasta Uses
  • Neutropenia Management – Increases white blood cell count during chemotherapy.
  • Infection Prevention – Reduces the risk of infections during cancer treatment.
  • Improved Chemotherapy Tolerance – Helps patients endure chemotherapy with fewer complications.

Pegasta supports patients by enhancing their immune system’s response to chemotherapy, enabling faster recovery and safer treatment.

Side Effects of Pegasta

Common side effects of Pegasta may include:

  • Bone pain
  • Headache
  • Fatigue
  • Nausea
  • Muscle pain

Less Common Side Effects

Less frequent but more serious side effects may include:

  • Splenic rupture
  • Severe allergic reactions
  • Respiratory distress
  • Abnormal heart rate

We are pleased to offer you this product.

Pegasta is a vital component in cancer treatment regimens, ensuring that patients undergoing chemotherapy receive the necessary immune support to stay healthy during their treatment cycle.

  • Pegasta is administered as an injection by a healthcare provider.
  • The dosage is typically once per chemotherapy cycle as prescribed by your doctor.
  • Follow the healthcare provider’s instructions on administration and monitoring.

Pegasta works by stimulating the bone marrow to increase production of neutrophils, which are essential for fighting infections. This action helps prevent infections in cancer patients whose immune systems are weakened by chemotherapy.

  • Reduces the risk of infection during chemotherapy.
  • Enhances the immune response of patients.
  • Helps improve recovery times for cancer patients.
  • Minimizes the risk of complications due to neutropenia.
  • Monitor for signs of allergic reactions and inform your doctor immediately.
  • Ensure proper hydration and avoid dehydration during use.
  • Discuss with your doctor any previous history of spleen issues.

Pegasta ensures cancer patients receive critical immune support during chemotherapy. Always follow your healthcare provider’s guidance for optimal results.